指南与共识消化、代谢与肾脏急症重症综合管理与镇静镇痛

拉丁美洲住院糖尿病患者使用瞬感连续血糖监测系统的推荐意见

Recommendations on the use of the flash continuous glucose monitoring system in hospitalized patients with diabetes in Latin America.
指南 / 共识 · Diabetol Metab Syndr · 2024-06-12
一句话结论专家共识推荐拉丁美洲住院糖尿病患者入院时或确认高血糖(>180 mg/dl)时启用瞬感连续血糖监测,并持续整个住院期间,扫描频率因年龄和糖尿病类型而异。

该专家共识采用改良德尔菲法,由九名专家组成小组,以80%为共识阈值,制定22个问题的工具,形成拉丁美洲住院糖尿病患者使用瞬感连续血糖监测系统(fCGM)的推荐。共识推荐入院时或确认高血糖(>180 mg/dl)时启用fCGM并持续整个住院期间;扫描频率因年龄和糖尿病类型不同:儿童1型和2型糖尿病、成人1型糖尿病及孕妇每日10次,成人2型糖尿病每日7次。急诊科、内科、重症监护病房、手术室和外科病房等多个科室可受益于fCGM。共识推荐在资源(设备、教育、人员)可用时,拉丁美洲医院糖尿病患者入院时即使用fCGM。

要点

  • 推荐住院糖尿病患者入院时或确认高血糖(>180 mg/dl)时启用fCGM,并持续整个住院期间。
  • 扫描频率因人群而异:儿童1型和2型糖尿病、成人1型糖尿病及孕妇每日10次;成人2型糖尿病每日7次。
  • 急诊科、内科、重症监护病房、手术室和外科病房均可受益于fCGM。
  • 推荐在资源(设备、教育、人员)可用时,拉丁美洲医院糖尿病患者入院时即使用fCGM。

适用人群与场景

  • 住院糖尿病患者,包括儿童1型和2型糖尿病、成人1型糖尿病、成人2型糖尿病及孕妇。
  • 适用场景包括急诊科、内科、重症监护病房、手术室和外科病房。

诊断标准与关键阈值

  • 启动阈值:入院时或确认高血糖(>180 mg/dl)时启用fCGM。

处置流程与药物剂量

  • 推荐入院时或确认高血糖(>180 mg/dl)时启用fCGM,并持续整个住院期间。
  • 扫描频率:儿童1型和2型糖尿病、成人1型糖尿病及孕妇每日10次;成人2型糖尿病每日7次。

研究设计与关键结果

  • 采用改良德尔菲法,由九名专家组成小组,以80%为共识阈值,制定22个问题的工具,形成推荐意见。

证据类型、等级与局限

  • 证据类型:专家共识(改良德尔菲法)。
  • 共识阈值:80%。

对床旁实践的改变

  • 推荐在资源(设备、教育、人员)可用时,拉丁美洲医院糖尿病患者入院时即使用fCGM。
  • fCGM可用于急诊科、内科、重症监护病房、手术室和外科病房的住院糖尿病患者。

指南或共识出处

  • 指南名称:Recommendations on the use of the flash continuous glucose monitoring system in hospitalized patients with diabetes in Latin America;发布机构:专家共识小组;发表期刊:Diabetology & Metabolic Syndrome。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Continuous glucose monitoring can improve glycemic control for hospitalized patients with diabetes, according to current evidence. However, there is a lack of consensus-established recommendations for the management of hospitalized patients with diabetes using flash continuous glucose monitoring system (fCGM) in Latin America. Therefore, this expert consensus exercise aimed to establish guidelines on the implementation of fCGM in the management of hospitalized patients with diabetes in Latin America.

METHODS: The modified Delphi method was applied on a panel of nine specialists, establishing consensus at 80%. A twenty-two-question instrument was developed to establish recommendations on the use of fCGM in hospitalized patients living with diabetes.

RESULTS: Based on consensus, experts recommend the use of fCGM in hospitalized patients with diabetes starting at admission or whenever hyperglycemia (> 180 mg/dl) is confirmed and continue monitoring throughout the entire hospital stay. The recommended frequency of fCGM scans varies depending on the patient's age and diabetes type: ten scans per day for pediatric patients with type 1 and 2 diabetes, adult patients with type 1 diabetes and pregnant patients, and seven scans for adult patients with type 2 diabetes. Different hospital services can benefit from fCGM, including the emergency room, internal medicine departments, intensive care units, surgery rooms, and surgery wards.

CONCLUSIONS: The use of fCGM is recommended for patients with diabetes starting at the time of admission in hospitals in Latin America, whenever the necessary resources (devices, education, personnel) are available.

来源:Diabetol Metab Syndr,查看原文。版权归原作者所有。

参考来源

  1. Gómez AM, Henao Carrillo DC, Ré MA, et al. Recommendations on the use of the flash continuous glucose monitoring system in hospitalized patients with diabetes in Latin America. Diabetol Metab Syndr. 2024. PMID: 38867297. doi:10.1186/s13098-024-01362-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。